ALLERGY THERAPEUTICS PLC

Report Publication Announcement • Mar 17, 2014

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4052C

Allergy Therapeutics PLC

17 March 2014

17 March 2014

Allergy Therapeutics plc

("Allergy Therapeutics" or the "Company")

Notice of results

Allergy Therapeutics plc (AIM: "AGY" or the "Company"), the fully integrated specialty pharmaceutical company specialising in allergy vaccines, will announce its Interim Results for the six months ended 31 December 2013 on Monday 24 March 2014.

- Ends -

For further information

Allergy Therapeutics	+44 (0) 1903 845 820
Manuel Llobet, Chief Executive Officer Ian Postlethwaite Finance Director
FTI Consulting
Simon Conway / Victoria Foster-Mitchell	+44 (0) 20 3727 1000

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORGMGMFRDNGDZM